Prodromal ?-Synucleinopathies Consortium (P?SS) (U19 Clinical Trial Optional)

Funding Opportunity RFA-AG-21-013 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications to develop a multisite, longitudinal, prospective study of idiopathic REM sleep behavior disorder (iRBD) as a prodromal phase of ?-synuclein neurodegenerative disorders.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding